Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
165 SAR | +0.49% | -0.84% | -3.96% |
May. 15 | Dallah Healthcare Company Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 13 | Dallah Healthcare Posts Higher Q1 Net Profit, Revenue | MT |
Sales 2024 * | 3.24B 864M | Sales 2025 * | 3.55B 947M | Capitalization | 16.12B 4.3B |
---|---|---|---|---|---|
Net income 2024 * | 445M 119M | Net income 2025 * | 505M 135M | EV / Sales 2024 * | 5.53 x |
Net Debt 2024 * | 1.81B 482M | Net Debt 2025 * | 1.71B 455M | EV / Sales 2025 * | 5.02 x |
P/E ratio 2024 * |
36.2
x | P/E ratio 2025 * |
31.2
x | Employees | - |
Yield 2024 * |
1.52% | Yield 2025 * |
1.83% | Free-Float | 41.94% |
1 day | +0.49% | ||
1 week | -0.84% | ||
1 month | +1.23% | ||
3 months | -12.05% | ||
6 months | -0.60% | ||
Current year | -3.96% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 67 | 08-03-28 | |
Salah Al-Faqih
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Talal Al-Maiman
BRD | Director/Board Member | - | - |
Chairman | 67 | 93-12-31 | |
Mohialdeen Kamel
BRD | Director/Board Member | 43 | 16-10-20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.02% | 112 M€ | +4.61% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-30 | 165 | +0.49% | 175,595 |
24-05-29 | 164.2 | +0.12% | 81,441 |
24-05-28 | 164 | -0.12% | 78,754 |
24-05-27 | 164.2 | -0.12% | 44,675 |
24-05-26 | 164.4 | -1.20% | 23,961 |
Delayed Quote Saudi Arabian S.E., May 30, 2024 at 08:20 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.96% | 4.3B | |
-23.39% | 15.56B | |
-2.70% | 11.65B | |
+2.65% | 11.58B | |
+2.37% | 10.06B | |
+29.48% | 8.7B | |
-10.45% | 7.16B | |
+8.05% | 6.85B | |
-4.29% | 5.71B | |
+13.33% | 4.3B |
- Stock Market
- Equities
- 4004 Stock